Yuan Ji

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Venues

Cancers

Statistical methods in medical research

Communications medicine

JCO precision oncology

The University of Chicago

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Chicago Oct 01 2018

United States

Professor :: Public Health Sciences

Publications

Tianjian Zhou, Yuan Ji
Bayesian Methods for Information Borrowing in Basket Trials: An Overview. Cancers 16 (2) (2024)
Tianjian Zhou, Yuan Ji
Bayesian Methods for Information Borrowing in Basket Trials: An Overview. Cancers 16 (2) (2024)
Abhinav Srinath, Bingqing Xie, Ying Li, Je Yeong Sone, Sharbel Romanos, Chang Chen, Anukriti Sharma, Sean P Polster, Pieter C Dorrestein, Kelly C Weldon, Dorothy DeBiasse, Thomas Moore, Rhonda Lightle, Janne Koskimäki, Dongdong Zhang, Agnieszka Stadnik, Kristina Piedad, Matthew J Hagan, Abdallah Shkoukani, Julián Carrión-Penagos, Dehua Bi, Le Shen, Robert Shenkar, Yuan Ji, Ashley Sidebottom, Eric G Pamer, Jack A Gilbert, Mark L Kahn, Mark D'Souza, Dinanath Sulakhe, Issam A Awad, Romuald Girard
Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma. Communications medicine 3 (1) (2023)
Abhinav Srinath, Bingqing Xie, Ying Li, Je Yeong Sone, Sharbel Romanos, Chang Chen, Anukriti Sharma, Sean P Polster, Pieter C Dorrestein, Kelly C Weldon, Dorothy DeBiasse, Thomas Moore, Rhonda Lightle, Janne Koskimäki, Dongdong Zhang, Agnieszka Stadnik, Kristina Piedad, Matthew J Hagan, Abdallah Shkoukani, Julián Carrión-Penagos, Dehua Bi, Le Shen, Robert Shenkar, Yuan Ji, Ashley Sidebottom, Eric G Pamer, Jack A Gilbert, Mark L Kahn, Mark D'Souza, Dinanath Sulakhe, Issam A Awad, Romuald Girard
Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma. Communications medicine 3 (1) (2023)
Haodong Ling, Haolun Shi, Nan Yuan, Yuan Ji, Xiaolei Lin
qTPI: A quasi-toxicity probability interval design for phase I trials with multiple-grade toxicities. Statistical methods in medical research (2023)
Xiaolei Lin, Jiaying Lyu, Shijie Yuan, Dehua Bi, Sue-Jane Wang, Yuan Ji
Bayesian Sample Size Planning Tool for Phase I Dose-Finding Trials. JCO precision oncology 6 (2022)
Daniel V T Catenacci, Stephanie Moya, Samantha Lomnicki, Leah M Chase, Bryan F Peterson, Natalie Reizine, Lindsay Alpert, Namrata Setia, Shu-Yuan Xiao, John Hart, Uzma D Siddiqui, Douglas Kyle Hogarth, Oliver S Eng, Kiran Turaga, Kevin Roggin, Mitchell C Posner, Paul J Chang, Sunil Narula, Murtuza Rampurwala, Yuan Ji, Theodore Karrison, Chih-Yi Liao, Blase N Polite, Hedy L Kindler
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer discovery 11 (2) (2020)
Xiaolei Lin, Yuan Ji
Probability intervals of toxicity and efficacy design for dose-finding clinical trials in oncology. Statistical methods in medical research 30 (3) (2020)
Carlos Tadeu Pagani Zanini, Peter Müller, Yuan Ji, Fernando A Quintana
A Bayesian random partition model for sequential refinement and coagulation. Biometrics 75 (3) (2019)
Marc Gillard, Rodrigo Javier, Yuan Ji, S Lilly Zheng, Jianfeng Xu, Charles B Brendler, Susan E Crawford, Brandon L Pierce, Donald J Vander Griend, Omar E Franco
Elevation of Stromal-Derived Mediators of Inflammation Promote Prostate Cancer Progression in African-American Men. Cancer research 78 (21) (2018)

Yuan Ji.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yuan Ji